Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
PUT
Ralph Lauren
RL
$22.1B
| $26.7M | 0.01% |
264,000
-38,100
| -13% | -$3.83M |
|
827
PUT
Jazz Pharmaceuticals
JAZZ
$16.5B
| $26.6M | 0.01% |
218,700
-13,300
| -6% | -$1.79M |
|
|
NAV
828
PUT
DELISTED
Navistar International
NAV
| $26.6M | 0.01% |
1,160,500
+818,700
| +240% | +$12.5M |
|
829
PUT
Southwest Airlines
LUV
$19.9B
| $26.5M | 0.01% |
682,600
-274,200
| -29% | -$10.4M |
|
830
Expedia Group
EXPE
$40.7B
| $26.5M | 0.01% |
227,000
+57,967
| +34% | +$6.56M |
|
831
PUT
Enterprise Products Partners
EPD
$82.8B
| $26.5M | 0.01% |
958,500
+53,500
| +6% | +$1.48M |
|
832
CALL
Lam Research
LRCX
$388B
| $26.4M | 0.01% |
2,790,000
+63,000
| +2% | +$573K |
|
833
CALL
Teck Resources
TECK
$34.4B
| $26.4M | 0.01% |
1,465,400
+398,500
| +37% | +$6.35M |
|
834
iShares Russell 1000 Value ETF
IWD
$84.3B
| $26.3M | 0.01% |
249,349
+21,945
| +10% | +$2.31M |
|
|
ALXN
835
DELISTED
Alexion Pharmaceuticals
ALXN
| $26.3M | 0.01% |
214,806
+208,042
| +3,076% | +$26.8M |
|
836
CALL
Parker-Hannifin
PH
$128B
| $26.3M | 0.01% |
209,600
-180,800
| -46% | -$21.5M |
|
837
iShares Russell 2000 Growth ETF
IWO
$15B
| $26.2M | 0.01% |
176,052
+92,972
| +112% | +$13.5M |
|
838
CALL
Signet Jewelers
SIG
$3.24B
| $26.2M | 0.01% |
351,700
-55,000
| -14% | -$4.65M |
|
839
PUT
CSX Corp
CSX
$95.3B
| $26.1M | 0.01% |
2,570,400
-276,300
| -10% | -$2.61M |
|
|
MNDT
840
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $26M | 0.01% |
1,767,301
+935,556
| +112% | +$14.4M |
|
841
PUT
GameStop
GME
$8.09B
| $26M | 0.01% |
3,768,800
+142,000
| +4% | +$1.03M |
|
|
KSU
842
PUT
DELISTED
Kansas City Southern
KSU
| $26M | 0.01% |
278,400
+111,200
| +67% | +$10.5M |
|
|
SLCA
843
CALL
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $25.9M | 0.01% |
556,400
-316,100
| -36% | -$12.3M |
|
844
CALL
Travel + Leisure Co
TNL
$4.48B
| $25.9M | 0.01% |
851,889
+172,548
| +25% | +$5.51M |
|
845
CALL
Children's Place
PLCE
$58M
| $25.9M | 0.01% |
324,100
+1,400
| +0.4% | +$115K |
|
846
CALL
American Electric Power
AEP
$66.4B
| $25.9M | 0.01% |
402,900
+37,900
| +10% | +$2.55M |
|
|
TPH
847
DELISTED
Tri Pointe Homes
TPH
| $25.7M | 0.01% |
1,949,387
-1,218,557
| -38% | -$16.1M |
|
848
PUT
Carnival Corporation Ltd
CCL
$35.2B
| $25.7M | 0.01% |
526,100
+78,400
| +18% | +$3.63M |
|
849
PUT
Public Storage
PSA
$60.7B
| $25.6M | 0.01% |
114,900
+86,600
| +306% | +$20.2M |
|
850
PUT
Ionis Pharmaceuticals
IONS
$10.3B
| $25.6M | 0.01% |
699,300
-26,900
| -4% | -$842K |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.57B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,275 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.